Abstract Background Monoclonal antibody therapies have a growing role in treating refractory airway disease. Objective The review aimed to summarise the response of respiratory mucosa to monoclonal antibody treatments in inflammatory airway conditions. Design We conducted a systematic review including risk of bias assessment. Data sources MEDLINE, Embase and Pubmed from 1 January 2000 to 16 November 2019 were searched. Eligibility criteria Eligible studies assessed the...
Mark above section as read
Abstract Purpose of Review This review highlights the expression and regulation of mucin in CRS and discusses its clinical implications. Recent Findings Chronic rhinosinusitis (CRS) is common chronic nasal disease; one of its main manifestations and important features is mucus overproduction. Mucin is the major component of mucus and...
Mark above section as read
Mark above section as read
Publication date: Available online 18 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Jyotsna Mullur, Alberta Wang, Anna Feldweg
Publication date: Available online 18 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Stanley M. Fineman, John Oppenheimer, Vivian Hernandez-Truillo, Bradley E. Chipps
Publication date: Available online 17 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Minxue Shen, Yangjian Xiao, Yan Yuan, Xiang Chen, Jie Li
Publication date: Available online 17 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Neha Puar, Raj Chovatiya, Amy S. Paller
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου